Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Waters’ Synapt HDMS System being used by XenoTech

Waters’ Synapt HDMS System being used by XenoTech

18th February 2009

Waters’ Synapt High Definition Mass Spectrometry (HDMS) System is being used by Xenotech as part of its new metabolite profiling services offering.

The device is incorporated with the former’s Acquity UltraPerformance Liquid Chromatograph and is set to be used in drug candidate investigation as well as in vitro metabolic profiling.

Andrew Parkinson, XenoTech’s chief executive officer, said the system is a "perfect fit" for the company’s operational requirements and scientific expectations.

Director of drug metabolism and analytical chemistry at the company, Paul Toren, added the company was "convinced" it was "the instrument for XenoTech’s lab".

According to the firm, in vitro metabolic profiling lowers the demand for time-consuming and expensive pre-clinical studies.

Studies involving the technique allow scientists to ascertain if an adverse reaction could arise from a drug candidate.

Earlier this month, Water acquired the remaining capital stock of Thar Instruments, while in June 2007, the former made an equity investment in the latter.

Those interested in science sales jobs may be surprised to hear Waters’ 2009 earnings figures are expected to be unaffected by the completion of the deal.ADNFCR-1050-ID-19033184-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.